FDA Drug recall D-0928-2017
BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Prince…
- FDA Drug
- Class III
- terminated
- Published 2017-07-05
On 2017-07-05 the FDA classified a Class III recall of BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Prince… by Mckesson Packaging Services, citing failed Moisture Limits: Product tested out-of-specification for moisture content.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0928-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-05-30 |
| Published | 2017-07-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mckesson Packaging Services |
| Distribution | US |
Product
BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10
Reason
Failed Moisture Limits: Product tested out-of-specification for moisture content.
Identifiers
| code_info | Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0928-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.